Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma (UCDCC#208)
This study is ongoing, but not recruiting participants.
Sponsor:
University of California, Davis
Collaborators:
Genentech
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00795665
First received: November 20, 2008
Last updated: March 26, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |